{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:45:48Z","timestamp":1779939948163,"version":"3.53.1"},"reference-count":40,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T00:00:00Z","timestamp":1202688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> Probiotics are widely studied both in the treatment and prevention of allergic diseases, but their mode of action is poorly known.<\/jats:p><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> Our aim was to examine the effect of probiotic bacteria on <jats:italic>in vivo<\/jats:italic> cytokine, antibody, and inflammatory responses in allergy\u2010prone infants.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> In a randomized double\u2010blind study, probiotic bacteria or placebo were given for 1 month before delivery to mothers and for 6 months to infants with a family history of allergy. Plasma samples were analysed for C\u2010reactive protein (CRP), total IgA and IgE, food\u2010specific IgA, IgG, and IgE, IL\u20102, IL\u20104, IL\u20106, IL\u201010, TNF\u2010\u03b1, and IFN\u2010\u03b3. We analysed the associations of immunological and inflammatory parameters at age 6 months with probiotic treatment and allergic phenotype at 2 years.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Infants receiving probiotic bacteria had higher plasma levels of CRP (<jats:italic>P<\/jats:italic>=0.008), total IgA (<jats:italic>P<\/jats:italic>=0.016), total IgE (<jats:italic>P<\/jats:italic>=0.047), and IL\u201010 (<jats:italic>P<\/jats:italic>=0.002) than infants in the placebo group. Increased plasma CRP level at age 6 months was associated with a decreased risk of eczema [odds ratio (OR) 0.41 [95% confidence interval (CI) 0.17\u20130.99], <jats:italic>P<\/jats:italic>=0.046], and with a decreased risk of allergic disease [OR 0.38 (95% CI 0.16\u20130.87), <jats:italic>P<\/jats:italic>=0.023] at age 2 years, when adjusted with probiotic use.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> The association of CRP with a decreased risk of eczema at 2 years of age in allergy\u2010prone children supports the view that chronic, low\u2010grade inflammation protects from eczema. Probiotic\u2010induced low\u2010grade inflammation was characterized by elevation of IgE, IgA, and IL\u201010, the changes typically observed in helminth infection\u2010associated induction of regulatory mechanisms. The findings emphasize the role of chronic microbial exposure as an immune modulator protecting from allergy.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2008.02942.x","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T09:36:24Z","timestamp":1202722584000},"page":"611-618","source":"Crossref","is-referenced-by-count":122,"title":["Probiotics in infancy induce protective immune profiles that are characteristic for chronic low\u2010grade inflammation"],"prefix":"10.1111","volume":"38","author":[{"given":"E.","family":"Marschan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kuitunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kukkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Poussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sarnesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Haahtela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Korpela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Savilahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Vaarala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,11]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"91","article-title":"Probiotics","volume":"61","author":"Sanders ME.","year":"2003","journal-title":"considerations for human health"},{"key":"e_1_2_6_3_2","first-page":"1076","article-title":"Probiotics in primary prevention of atopic disease","volume":"357","author":"Kalliom\u00e4ki M","year":"2001","journal-title":"a randomised placebo-controlled trial"},{"key":"e_1_2_6_4_2","first-page":"1869","article-title":"Probiotics and prevention of atopic disease","volume":"361","author":"Kalliom\u00e4ki M","year":"2003","journal-title":"4-year follow-up of a randomized placebo-controlled trial"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00943.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.389"},{"key":"e_1_2_6_7_2","first-page":"494","article-title":"Probiotics in the treatment of atopic eczema\/dermatitis syndrome in infants","volume":"60","author":"Viljanen M","year":"2005","journal-title":"a double-blind placebo-controlled trial"},{"key":"e_1_2_6_8_2","first-page":"892","article-title":"Effects of probiotics on atopic dermatitis","volume":"90","author":"Weston S","year":"2005","journal-title":"a randomised controlled trial"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.4049\/jimmunol.159.4.1739","article-title":"The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction","volume":"159","author":"Sudo N","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00054"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.12.6058-6062.1998"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.62.7.2715-2721.1994"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.03.036"},{"key":"e_1_2_6_14_2","first-page":"179","article-title":"Probiotics","volume":"99","author":"Majamaa H","year":"1997","journal-title":"a novel approach in the management of food allergy"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.03.047"},{"key":"e_1_2_6_16_2","first-page":"192","article-title":"Probiotics and prebiotic galacto\u2010oligosaccharides in the prevention of allergic diseases","volume":"119","author":"Kukkonen K","year":"2007","journal-title":"a randomized double-blind placebo-controlled trial"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2006.00420.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08532.x"},{"key":"e_1_2_6_19_2","first-page":"832","article-title":"Revised nomenclature for allergy for global use","volume":"113","author":"Johansson SG","year":"2004","journal-title":"report of the nomenclature review committee of the world allergy organization, October 2003"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247298"},{"key":"e_1_2_6_21_2","first-page":"1","article-title":"Skin tests used in type I allergy testing. Position paper. EAACI Sub\u2010Committee on Skin Tests","volume":"44","author":"Dreborg S","year":"1989","journal-title":"Allergy"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1995.tb02579.x"},{"key":"e_1_2_6_23_2","first-page":"S147","article-title":"Expert Panel Report. Long\u2010term management of asthma in children","volume":"110","author":"National Asthma Education and Prevention Program.","year":"2002","journal-title":"effectiveness of inhaled corticosteroids compared to other medications"},{"key":"e_1_2_6_24_2","first-page":"S1","article-title":"International Consensus Report on the diagnosis and management of rhinitis","volume":"49","author":"International Rhinitis Management Working Group.","year":"1994","journal-title":"Allergy"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.7.984"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70094-1"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.296.5567.490"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2005.09.001"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042572"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02157.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.123307"},{"key":"e_1_2_6_32_2","first-page":"1723","article-title":"Decreased atopy in children infected with Schistosoma haematobium","volume":"356","author":"Van Den Biggelaar AH","year":"2000","journal-title":"a role for parasite-induced interleukin-10"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1987.tb02004.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/381767"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)93319-5"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2000.tb01504.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.06.068"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/50.2.68"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.9.6256"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6710.1259"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0304-232"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2008.02942.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2008.02942.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:01:19Z","timestamp":1697234479000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2008.02942.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1365-2222.2008.02942.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2008.02942.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,11]]}}}